Quantitation of Alzheimer's disease biomarkers in plasma using SMC ^® high sensitivity immunoassays

This study demonstrates the value of using multiplex high sensitivity technology to evaluate multiple biomarkers in the same sample. The SMC^® Aβ42/Aβ40 high sensitivity immunoassay kit serves as a powerful non-invasive biomarker tool for monitoring the progression of neurodegenerative diseases such as Alzheimer's disease while saving time and sample. Further studies into other combinations of AD biomarkers will determine if their ratios would also serve as valuable measures of AD related neurodegeneration.